Device Maker Medmari Expects High Sales Through Reclassification Of Its Rapid HIV Test In China
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China's State FDA has approved and reclassified Canadian device maker MedMari's rapid HIV test as a medical device in China, which will increase sales opportunities for the product, the company announced